Introduction {#sec0005}
============

West Nile virus (WNV) is a mosquito-borne flavivirus belonging to the Japanese encephalitis serocomplex of the family Flaviviridae \[[@bib0005]\]. *Culex* spp. are the most common vectors of WNV transmitting infection to humans and birds serve as reservoirs \[[@bib0005],[@bib0010]\]. Person-to-person transmission is not common but can result from blood transfusion, organ transplantation, intrauterine or breastfeeding exposure \[[@bib0010]\].

In 80 % of the cases, infection is asymptomatic and in the rest clinical manifestations include acute febrile illness with symptoms of a respiratory infection, often with the development of meningitis and meningoencephalitis \[[@bib0015],[@bib0020]\]. Neuroinvasive WNV disease occurs in less than 1% of cases, following viral penetration of the blood--brain barrier and direct invasion into neurons, particularly those in the brainstem, deep nuclei, and anterior horn of the spinal cord. Neuroinvasive WNV disease could result in significant morbidity and mortality. Thus, high clinical suspicion is necessary to diagnose this disease.

WNV-related neuroinvasive manifestations are various and include aseptic meningitis, meningoencephalitis and acute flaccid paralysis syndrome (a poliomyelitis-like illness). The proportion of neuroinvasive disease manifesting as meningitis, as opposed to encephalitis or myelitis, has varied greatly within a given epidemic season and locale. A number of nonspecific symptoms may provide a clue to the diagnosis of central nervous system infection with WNV, as in other forms of encephalitis, such as fever (in 70--100 % of patients), headache (50--100 % of patients) and altered mental status (50--100 % of patients), vomiting (30--75 % of patients), diarrhea (15--35 % of patients) and rash (5--50 % of patients). Flaccid paralysis is observed in a significant proportion of patients (30--50 %). Other distinctive findings include cranial neuropathies and most commonly unilateral or bilateral peripheral facial palsy. Also, dyskinesias is common in patients with WNV meningoencephalitis, and can include postural or kinetic tremor (in up to 90 % of patients), parkinsonism (including cogwheel rigidity, bradykinesia and postural instability \[70 %\]), and myoclonus \[[@bib0025]\].

WNV is spread globally \[[@bib0005]\]. Several outbreaks of WNV infection cases have been reported in a number of countries \[[@bib0030], [@bib0035], [@bib0040]\]. WNV has also been widely registered in the neighboring with Kazakhstan countries: Russia, Turkmenistan, Uzbekistan and China \[[@bib0045]\]. In Kazakhstan, WNV isolation from mosquitoes and WNV seropositivity in humans have been reported in the West-Kazakhstan region \[[@bib0050],[@bib0055]\]. Also, recently, circulation of WNV in the southern region of Kazakhstan (Turkestan region) has been confirmed by the population screening \[[@bib0060]\].

Due to the facts that WNV occurs in the neighboring with Kazakhstan countries and that the number of cases of meningoencephalitis and fevers of unknown origin has steadily been increasing in the Almaty region in the past decade, we performed a pilot study aimed at the evaluation of WNV seroprevalence in the healthy population and patients with fevers of unknown origin. Commercial immunoassays VectorNile-IgM and VectorNile-IgG, VectorBest (Russia) were used for detection of sera IgM and IgG antibodies against WNV. WNV IgG were detected in 19.8 % (37/187) of the tested asymptomatic residents of the Almaty region. WNV IgM were detected in 2.4 % (5/209) of sera samples obtained from febrile patients with fevers of unknown origin during the 2018--2019 epidemiological season. Thus, preliminary results confirmed active circulation of WNV in the Almaty region of Kazakhstan and allowed us to identify WNV clinical cases among the patients with appropriate clinical manifestation.

Here we describe two cases from one family with clinical symptoms of neuroinvasive WNV infection and positive WNV serology which occurred in the Almaty region of Kazakhstan.

Methods {#sec0010}
=======

Study design {#sec0015}
------------

This is a retrospective study of cases of fever of unknown origin with neurological manifestations reported during the 2019 epidemiological season aimed to confirm active circulation of WNV in the Almaty region of Kazakhstan. Archived serum samples were retrospectively tested for WNV and the clinical data of the patients, which serum samples were positive for WNV, were selected and analyzed. The clinical data were gathered from medical records without any personally identifiable information. The local ethics committee of the National Center for Biotechnology has approved the study ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1**Geographic distribution of WNV by regions in Kazakhstan.** Geographic distribution of reported WNV positive human sera and mosquitoes in the regions of Kazakhstan is depicted. '\*' indicates the location of described human WNV clinical cases.Fig. 1

Serological analysis {#sec0020}
--------------------

Archived serum samples were retrieved from storage at −20 °C at a local hospital. These serum samples had been obtained from patients on day 9 after onset of symptoms and previously tested for tick-borne encephalitis. For serological analysis, serum samples were thawed and inactivated at 56 °C for 20 min. Commercial assays (VectorNile-IgM and VectorNile-IgG, VectorBest, Russia) were used as directed by the manufacturer. The results were calculated by dividing the optical density (OD) values of the test sera by the OD values of the Cutoff Calibrator. Indicators above 0.478 for IgM and 0.355 for IgG were considered positive.

Cases {#sec0025}
=====

Case 1 {#sec0030}
------

A 28-year-old male from the rural Syrymbet village (44.8601 °N, 78.7629 °E), Eskeldinsky district, Almaty region, Kazakhstan, was admitted to the emergency department of a hospital in Tekeli city (Almaty region, Kazakhstan) on August 2, 2019, with a 3-day febrile illness. His symptoms started on July 31 (day 1) with fever and headache. On day 2 his fever raised up to 39.0 °C (axillary temperature), headache intensified and the patient began vomiting. Oral analgesics and nonsteroidal anti-inflammatory drugs did not improve patient's condition.

Upon admission, physical assessment revealed fever (39.0 °C axillary temperature), nausea and vomiting, blood pressure 140/90 mmHg, heart rate 72--88 bpm, muffled heart sounds, respiratory rate 18/min, weakness, malaise, severe headache, and photophobia. Patient's throat was hyperemic, tongue had white coating, liver was palpated at the edge of the rib arch. Neck muscle rigidity (40 mm), Kernig\'s sign on the both sides, and lower motor neuron type facial palsy were observed. The patient denied tick bites. Cerebrospinal fluid (CSF) opening pressure was 180 mmH~2~O. CSF pleocytosis (26 cells/mL) with decreased lymphocyte counts (12.0 cells/mL; 46.1 %), neutrophil predominance (14.4 cells/mL; 53.9 %), and mild protein concentration (33.0 mg/dl) were detected.

On day 4 after symptoms onset, laboratory tests showed that the erythrocyte sedimentation rate (ESR) (26 mm/hr), blood white blood cell counts and urine tests were within the normal range. Bacterial culture of the CSF and the nasopharyngeal swab were negative for *Meningococcus* and other species of *Neisseria*. Also, serological analysis for herpes viruses, enterovirus infection and tick-borne encephalitis showed negative results.

Based on the clinical findings, the patient was diagnosed with aseptic meningitis and treated with symptomatic therapy.

The Kernig\'s sign, vomiting and pharyngeal hyperemia disappeared on day 4 and 5 since onset of illness, respectively. The patient continued to be febrile until day 9. Neck stiffness and increased blood pressure were observed until day 10. Weakness, malaise, and headache lasted for 11 days of illness. He was discharged in 14 days after symptoms onset with near-complete recovery.

The patient's initial serum sample taken on day 9 after symptom onset was retrospectively assessed for WNV by ELISA. Serum specimen obtained from the patient was negative for WNV IgM and positive for WNV IgG (the OD value of the sample exceeded the OD value of the Cutoff Calibrator more than 15 times (OD value -- 4.482)).

Case 2 {#sec0035}
------

The first case patient's 19-year old wife was hospitalized to the Tekeli city hospital, Almaty region, Kazakhstan on August 5, 2019, with the same initial diagnosis of acute respiratory viral infection, meningism. She fell ill on August 4 (day 1), 5 days later her husband. Upon admission, she had high fever (maximum axillary temperature of 39.8 °C), weakness, malaise, dizziness, photophobia, nausea, and moderate headache for 2 days.

Physical findings were as follows: fever (axillary temperature of 39.7 °C); nausea and vomiting; blood pressure 140/90 mmHg; heart rate 94 bpm; muffled heart sounds; respiratory rate 20/min; hyperemic mucosa of the pharynx and posterior pharyngeal wall; thick white coating on the tongue; liver was palpated at the edge of the rib arch. Neck muscle stiffness (30 mm), Kernig\'s sign, lower motor neuron type facial palsy, tremor in the hands and leg, and carpopedal spasms were also noted. A lumbar puncture revealed a CSF opening pressure at 180 mmH2O, pleocytosis (20 cells/mL) with low lymphocyte (15.0 cells/mL; 75.0 %) and neutrophil (5 cells/mL; 25.0 %) counts, and a significantly elevated protein concentration (264 mg/dl). Laboratory evaluation showed an elevated white blood cell (WBC) count of 10.3/μl with an increase in neutrophil numbers (81.5 %) accompanied with a decrease in lymphocyte numbers (10.0 %). On the second day of illness, the ESR was 23 mm/hr (normal value \< 15 mm/hr). Urine tests were within the normal range. Serological analysis and bacterial culture tests showed negative results for *Neisseria* species, herpes viruses, enterovirus infection and tick-borne encephalitis.

The patient was diagnosed with aseptic meningitis and prescribed symptomatic therapy with additional empiric antiviral therapy (Rimantadine (1.5 mg/kg in 3 doses for 2 days and then in 2 doses for 4 days)).

The patient improved after the initiation of the treatment. She was completely afebrile on day 3 after symptom onset. The Kernig\'s sign, vomiting and pharyngeal hyperemia disappeared on day 3. Neck stiffness and increased blood pressure were observed until day 8 and 9, respectively. She was discharged after on day 11 of illness with near-complete improvement and without neurologic sequelae.

Retrospective serological analysis showed the absence of IgM and high titers of IgG (OD value of the sample 11 times exceeded the OD value of the Cutoff Calibrator (OD value -- 4.212)) against WNV in the patient's serum sample obtained on day 9 after symptom onset.

Discussion {#sec0040}
==========

Neuroinvasive WNV infection is associated with significant morbidity. The diagnosis of neuroinvasive disease in WNV infection is based on several factors like exposure to the vector, living in an endemic area, and the clinical manifestations. In endemic areas, the diagnosis should be considered, especially in the summer \[[@bib0065]\].

WNV circulation has been previously demonstrated in the West-Kazakhstan and Turkestan regions of Kazakhstan \[[@bib0050], [@bib0055], [@bib0060]\]. However, despite evidence of the virus circulation, documented cases of WNV infection have not been reported in Kazakhstan. In the Almaty region of Kazakhstan over the past decade, the number of cases of meningoencephalitis and fever of unknown origin has been increasing \[[@bib0070]\]. However, patients are not suspected for WNV infection in clinics due to a persistent misconception that the disease does not occur in the southern region of the country.

Our pilot screening study showed the positivity for anti-WNV IgG and anti-WNV IgM in healthy residents and patients with fevers of unknown of the Almaty region. We assume that sporadic cases or small clusters of WNV disease had previously occurred in the southern region of Kazakhstan and remained undiagnosed due to the overlapping of the neurological symptoms attributable to several other viral infections of the central nervous system \[[@bib0075], [@bib0080], [@bib0085]\] and limitations in the availability of diagnostic resources in most hospitals within the Almaty region, Kazakhstan. As an example, here we give a brief summary of the medical histories of two patients whose serum taken on day 9 of illness showed the presence of high titers of IgG for WNV.

Two family members, a husband and his wife, manifested a febrile illness with a difference of 4 days. The symptoms observed in these patients were consistent with meningitis that started abruptly. Laboratory tests for the presence of other etiological factors of meningitis and encephalitis were negative. In both cases, the disease manifestated in August, which is consistent with the seasonal outbreaks of WNV infection \[[@bib0005]\].

The territory of Almaty region is characterized by a sharply continental climate with warm springs and summers. Tekeli city is located in the south-east of Kazakhstan, at the foothills of the northern of Tien Shan ridge - Jungarsky Alatau and characterized by large amounts of rainfall and high number of surrounded natural reservoirs, which benefit mosquito breeding. In August, the average temperatures vary from 15 °C to 29 °C and average precipitation is 13 mm. The main vectors for WNV are mosquito species of the *Culex* genus, but WNV has also been previously detected in several Aedes *and* Anopheles spp. \[[@bib0090]\]. The mosquito fauna in the Almaty region is represented by 20 species of genera *Culex, Anopheles, and Aedes* that are potentially able to transmit WNV to humans \[[@bib0095],[@bib0100]\] (*Cx. theileri, Cx. modestus, Cx. pipiens pipiens, Cx. p. molestus, An. maculipennis, An. pulcherrimus, An. claviger, An. messeae, Ae. caspius caspius, Ae. c. dorsalis, Ae. straminaeus, Ae. cantans, Ae. flavescens, Ae. cyprius, Ae. pionips, Ae. pullatus, Ae. catarphylla, Ae. leucomelas, Ae. vexans, Ae. cinereus*). *Aedes spp.* mosquitoes become active in late March -- early April and reach their peak numbers in June. The species of genera *Culex* and *Anopheles* appear in middle April reaching two peaks in numbers in early June and in the end of July \[[@bib0105]\].

Performed retrospective serological analysis showed the absence of anti-WNV IgM and high titers of anti-WNV IgG in both patients. Although detection of IgG alone does not indicate acute infection, but rather a prior infection, the obtained results raise suspicion for WNV endemicity in this region. Also, this study was limited by the unavailability of neutralizing antibody testing and by the absence of convalescent-phase serum samples. Possible cross-reactivity with tick-borne encephalitis virus reported earlier \[[@bib0110]\] has been excluded due to negative serological results. Also, both patients live in Eskeldinsky district, which borders northwest China, where WNV is widely distributed \[[@bib0115]\]. Thus, we can assume the background of WNV infection in both patients.

There is no specific treatment for WNV disease \[[@bib0120]\] and most of the viruses that cause meningitis \[[@bib0125]\]. Patients with severe meningeal symptoms often require pain control for headaches and antiemetic therapy and rehydration for associated nausea and vomiting \[[@bib0120]\]. In the observed cases, patients responded favorably to unspecific supportive therapy and recovered within 8--10 days from neurological sequelae.

The results of the study raise suspicion of WNV circulation in the southern region of Kazakhstan. Therefore, patients with meningoencephalitis of suspected viral etiology in the area must also be evaluated for WNV.

Conclusion {#sec0045}
==========

To our knowledge these cases represent the first description of acute meningoencephalitis due to WNV infection in the Almaty region, Kazakhstan. These cases illustrate that a compatible clinical syndrome and seasonal context for WNV should prompt testing for the presence of WNV immunoglobulins in the serum and CSF. More research and surveillance studies are needed to understand the true incidence and prevalence of WNV infection in the southern region of Kazakhstan.
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